A Study of the Safety, Tolerability and Pharmacokientics of RO5545965 in Patients With Schizophrenia on Risperidone

NCT02019329 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

OTHER: Placebo
DRUG: RO5545965
DRUG: risperidone

Sponsor

Hoffmann-La Roche